Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17 Beta Hydroxy 5 Beta Androstan 3 One
2. 17 Beta-hydroxy-5 Beta-androstan-3-one
3. 17beta Hydroxy 5alpha Androstan 3 One
4. 17beta-hydroxy-5alpha-androstan-3-one
5. 5 Alpha Dht
6. 5 Alpha Dihydrotestosterone
7. 5 Alpha-dihydrotestosterone
8. 5 Beta Dihydrotestosterone
9. 5 Beta-dihydrotestosterone
10. 5-alpha Dihydrotestosterone
11. 5-alpha-dht
12. Anaprotin
13. Andractim
14. Androstanolone
15. Beta-hydroxy-5 Beta-androstan-3-one, 17
16. Dihydroepitestosterone
17. Dihydrotestosterone
18. Dihydrotestosterone, 5-alpha
19. Gelovit
20. Stanolone
1. Etiocholan-17.beta.-ol-3-one
2. Anaprotin
3. 5.beta.,17.beta.-hydroxyandrostan-3-one
4. 5.beta.-androstan-3-one, 17.beta.-hydroxy-
5. 5.beta.-dihydrotestosterone
6. 5b-dihydrotestosterone
7. 17.beta.-hydroxyetiocholan-3-one
8. Nsc-15460
9. 5.beta.-androstan-17.beta.-ol-3-one
10. Androstan-3-one, 17-hydroxy-, (5.alpha.,17.beta.)-
11. Oprea1_456186
12. Schembl9340073
13. Bcp22808
14. Nsc15460
15. Nsc61692
16. Bbl028114
17. Nsc-61692
18. Stk366316
19. Akos002232213
20. Akos016303784
21. Ncgc00249620-01
22. Vs-08671
23. Ft-0662160
24. Ab00987792-01
25. 1-hydroxy-9a,11a-dimethyl-hexadecahydro-1h-cyclopenta[a]phenanthren-7-one
26. Andractim Pound>> Lg 152 Pound>>lg-152 Pound>> Lg152 Pound>> Stanolone Pound>> Dihydrotestosterone Pound>> Dihydrotestosterone Propionate
Molecular Weight | 290.4 g/mol |
---|---|
Molecular Formula | C19H30O2 |
XLogP3 | 3.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 290.224580195 g/mol |
Monoisotopic Mass | 290.224580195 g/mol |
Topological Polar Surface Area | 37.3 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 459 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 7 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Androgens
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)
ABOUT THIS PAGE
A Androstan-17B-Ol-3-One manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Androstan-17B-Ol-3-One, including repackagers and relabelers. The FDA regulates Androstan-17B-Ol-3-One manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Androstan-17B-Ol-3-One API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Androstan-17B-Ol-3-One supplier is an individual or a company that provides Androstan-17B-Ol-3-One active pharmaceutical ingredient (API) or Androstan-17B-Ol-3-One finished formulations upon request. The Androstan-17B-Ol-3-One suppliers may include Androstan-17B-Ol-3-One API manufacturers, exporters, distributors and traders.
Androstan-17B-Ol-3-One Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Androstan-17B-Ol-3-One GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Androstan-17B-Ol-3-One GMP manufacturer or Androstan-17B-Ol-3-One GMP API supplier for your needs.
A Androstan-17B-Ol-3-One CoA (Certificate of Analysis) is a formal document that attests to Androstan-17B-Ol-3-One's compliance with Androstan-17B-Ol-3-One specifications and serves as a tool for batch-level quality control.
Androstan-17B-Ol-3-One CoA mostly includes findings from lab analyses of a specific batch. For each Androstan-17B-Ol-3-One CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Androstan-17B-Ol-3-One may be tested according to a variety of international standards, such as European Pharmacopoeia (Androstan-17B-Ol-3-One EP), Androstan-17B-Ol-3-One JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Androstan-17B-Ol-3-One USP).
LOOKING FOR A SUPPLIER?